Effectiveness of Mannitol Use on Clinical Outcomes of Severe Traumatic Brain Injury Patients
- PMID: 39280770
- PMCID: PMC11393529
- DOI: 10.12688/f1000research.148102.1
Effectiveness of Mannitol Use on Clinical Outcomes of Severe Traumatic Brain Injury Patients
Abstract
Background: Head injuries are considered as a silent epidemic due to the high incidence rate throughout the world. The main cause of morbidity and mortality in patients with head injury is cerebral edema which is defined as abnormal fluid accumulation in the brain parenchyma. Mannitol is a hyperosmolar solution given to reduce fluid volume in the brain. Increased high intracranial pressure can affect prognosis and can be evaluated by assessing clinical outcomes in patients with severe traumatic brain injury using the Glasgow Outcome Discharge Scale (GODS) instrument.
Methods: Observational analytical study with a cross sectional design on 50 patients with severe traumatic brain injury at dr. Zainoel Abidin General Hospital Banda Aceh to determine the effect of mannitol use on the clinical outcomes of severe traumatic brain injury patients which used t test analysis.
Results: The mean value of the group that received mannitol had a higher GODS score than the group that did not receive mannitol. The results of the T test between groups obtained a p value of 0.000 which is smaller than 0.05, so it can be concluded that the use of mannitol has an effect on the GODS score in Severe traumatic brain injury patients. The results showed that the mean GODS value in patients who received mannitol was higher than those who did not receive mannitol.
Conclusion: This concludes that the administration of mannitol is effective in improving the clinical outcomes of patients with severe traumatic brain injury at dr. Zainoel Abidin General Hospital Banda Aceh.
Keywords: Clinical Outcome; GODS; Mannitol; Severe Traumatic Brain Injury.
Copyright: © 2024 Syahrul S et al.
Conflict of interest statement
No competing interests were disclosed.
Similar articles
-
Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury.J Neurosurg. 2015 Jan;122(1):202-10. doi: 10.3171/2014.10.JNS132545. J Neurosurg. 2015. PMID: 25380107 Clinical Trial.
-
Hypertonic saline versus other intracranial pressure-lowering agents for people with acute traumatic brain injury.Cochrane Database Syst Rev. 2020 Jan 17;1(1):CD010904. doi: 10.1002/14651858.CD010904.pub3. Cochrane Database Syst Rev. 2020. PMID: 31978260 Free PMC article.
-
Hyperosmolar therapy in the treatment of severe head injury in children: mannitol and hypertonic saline.AACN Clin Issues. 2005 Apr-Jun;16(2):199-211. doi: 10.1097/00044067-200504000-00011. AACN Clin Issues. 2005. PMID: 15876888 Review.
-
Hyperosmolar therapy in pediatric traumatic brain injury: a retrospective study.Childs Nerv Syst. 2016 Dec;32(12):2363-2368. doi: 10.1007/s00381-016-3231-y. Epub 2016 Aug 27. Childs Nerv Syst. 2016. PMID: 27568371
-
Comparison of Intracranial Pressure Measurements Before and After Hypertonic Saline or Mannitol Treatment in Children With Severe Traumatic Brain Injury.JAMA Netw Open. 2022 Mar 1;5(3):e220891. doi: 10.1001/jamanetworkopen.2022.0891. JAMA Netw Open. 2022. PMID: 35267036 Free PMC article.
References
-
- Heidenreich KA: New Therapeutics for Traumatic Brain Injury. United Kingdom: Elsevier Inc;2017.
-
- Syahrul I, Fajri N: Clinical Characteristics of Traumatic Brain Injury Patient in Dr. Zainoel Abidin Public Hospital Banda Aceh, Indonesia. Bali Med. J. 2020;9(1):194–200. 10.15562/bmj.v9i1.1726 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical